HighTower Advisors’s iShares Biotechnology ETF IBB Stock Holding History

HighTower Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$1K	–	2357
2019 Q4	$1K	Buy	+1,000	New	+$112K	﹤0.01%	2262
2019 Q2	–	Sell	-500	Closed	-$1K	–	2444
2019 Q1	$1K	Buy	+500	New	+$54.8K	﹤0.01%	2275
2017 Q1	–	Sell	-48,000	Closed	-$4K	–	2122
2016 Q4	$4K	Buy	+48,000	New	+$4.37M	﹤0.01%	1901
2014 Q2	–	Sell	-1,500	Closed	-$8K	–	1654
2014 Q1	$8K	Buy	+1,500	New	+$125K	﹤0.01%	1530

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HighTower Advisors's IBB Position: Q1 2026 in Review

HighTower Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.55% in Q1 2026, buying an estimated $65.8K and bringing the position to 70,904 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #807.

HighTower Advisors first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q1 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

HighTower Advisors held 70,904 shares of iShares Biotechnology ETF worth $12M as of Q1 2026.
HighTower Advisors bought 385 iShares Biotechnology ETF shares in Q1 2026, an estimated $65.8K.
iShares Biotechnology ETF made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #807 holding.
HighTower Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's iShares Biotechnology ETF position peaked at $13M in Q1 2019.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.